2007Guangxi Medical JournalRequires access

The clinical study on interventional thermochemotherapy and embolization treatment of the advanced patients with hepatocellular carcinoma

Bo Huang

Open publisher page 0 citations

Abstract

Objective To evaluate the efficacy and side effects of interventional thermochemotherapy and embolization treatment of the advanced patients with hepatocellular carcinoma.Methods One hundred patients of advanced hepatocellular carcinoma were randomly divided into hyperthermia group and ordinary group,each group had 50 cases.All patients received transcatheter arteria chemoembolization,chemothrapy with ADM,MMC,5-Fu,CDDP,and super-liquid iodided oil was used.The tumor growth rate were recorded and all patients were followed up by examinations of AFP,ALT and AST.Results The tumor growth rate of hyperthermia group and ordinary group were(-8.56±28.42%),(10.25±43.3)%,respectively.There was significant statistial difference between the two groups(P0.05).There were significant statistical differences in level of AFP before and after procedure in the hyperthermia group and in the survival rate for 0.5,1,1.5,2 years between the two groups(P0.05),but there were no significant statistical differences in the level of positive ALT and AST and side effects between the two groups(P0.05).Conclusion The interventional thermochemotherapy and embolization treatment can effectively prolonged survival of the advanced patients with hepatocellular carcinoma.

About this research paper

What this paper is about

Objective To evaluate the efficacy and side effects of interventional thermochemotherapy and embolization treatment of the advanced patients with hepatocellular carcinoma.Methods One hundred patients of advanced hepatocellular carcinoma were randomly divided into hyperthermia group and ordinary group,each group had 50 cases.All patients received transcatheter arteria chemoembolization,chemothrapy with ADM,MMC,5-Fu,CDDP,and super-liquid iodided oil was used.The tumor growth rate were recorded and all patients were followed up by examinations of AFP,ALT and AST.Results The tumor growth rate of hyperthermia group and ordinary group were(-8.56±28.42%),(10.25±43.3)%,respectively.There was significant statistial difference between the two groups(P0.05).There were significant statistical differences in level of AFP before and after procedure in the hyperthermia group and in the survival rate for 0.5,1,1.5,2 years between the two groups(P0.05),but there were no significant statistical differences in the level of positive ALT and AST and side effects between the two groups(P0.05).Conclusion The interventional thermochemotherapy and embolization treatment can effectively prolonged survival of the advanced patients with hepatocellular carcinoma.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To evaluate the efficacy and side effects of interventional thermochemotherapy and embolization treatment of the advanced patients with hepatocellular carcinoma.Methods One hundred patients of advanced hepatocellular carcinoma were randomly divided into hyperthermia group and ordinary group,each group had 50 cases.All patients received transcatheter arteria chemoembolization,chemothrapy with ADM,MMC,5-Fu,CDDP,and super-liquid iodided oil was used.The tumor growth rate were recorded and all patients were followed up by examinations of AFP,ALT and AST.Results The tumor growth rate of hyperthermia group and ordinary group were(-8.56±28.42%),(10.25±43.3)%,respectively.There was significant statistial difference between the two groups(P0.05).There were significant statistical differences in level of AFP before and after procedure in the hyperthermia group and in the survival rate for 0.5,1,1.5,2 years between the two groups(P0.05),but there were no significant statistical differences in the level of positive ALT and AST and side effects between the two groups(P0.05).Conclusion The interventional thermochemotherapy and embolization treatment can effectively prolonged survival of the advanced patients with hepatocellular carcinoma.

Key concepts: Hepatocellular carcinoma, Medicine, Embolization, Hyperthermia, Internal medicine, Gastroenterology, Transcatheter arterial chemoembolization, Survival rate

Related papers

Back to paper searchBrowse research topicsOriginal source
The clinical study on interventional thermochemotherapy and embolization treatment of the advanced patients with hepatocellular carcinoma — Research Paper | ScholarLens